Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke

Completed

Phase 2 Results N/A

Summary of Purpose

Astragalus membranaceus (AM) is used to treat stroke for a long period, and a number of studies have known that AM can reduce cerebral infarction area and has anti-oxidation. Hemorrhagic stroke will induce secondary peri-blood clot edema and that may increase intracranial pressure to exacerbate clinical symptom. Therefore, the purpose of the present study was to investigate the effect of AM on hemorrhagic stroke...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 September 2011.

1 Jan 2008 1 Sep 2011 1 Dec 2010 1 Mar 2011 1 Sep 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available